Advertisement
Cato Research will provide business development, personnel training,senior management recruitment and implementation of SOP guidelines. Incollaboration with Cato BioVentures, the venture capital affiliate of CatoResearch, Cato Research will also provide CRO services to include clinicalstudies, data management activities, statistical analysis, as well asregulatory services.
Advertisement
"This joint venture further allows Cato to expand its internationalpresence and better serve our sponsors," said Dr. Allen Cato, M.D., Ph.D.,Chief Executive Officer of Cato Research and Principal of Cato BioVentures."The addition of India into Cato Research's international network increasesour ability to conduct multinational clinical trials and provide a wide rangeof CRO services in the international arena."
"We are pleased to be working with Cato Research and Cato BioVentures toaccelerate development and commercialization of several new innovativeproducts," said Dr. D. R. Rao, Chairman and Managing Director for NeulandLaboratories. "Our strategic interests are well-aligned, as each party offersunique strengths to make this arrangement successful. This joint venture takesNeuland one step closer towards our objective of becoming an end-to-endservice provider for the Pharmaceutical Industry."
About Cato Research Ltd.
Founded in 1988 by Dr. Allen Cato and Lynda Sutton and headquartered nearResearch Triangle Park, North Carolina, Cato Research is a global full-servicecontract research and development organization providing strategic andtactical support for clients in the pharmaceutical, biotechnology, medicaldevice, and medical diagnostic industries. With a staff of nearly 300employees located in the United States, Europe, Canada, Israel, and SouthAfrica, Cato Research's services range from design and management ofpreclinical and clinical studies to submission of regulatory documentsrequired for marketing approval.
About Neuland Laboratories
The company, which was founded in 1984 and is based in Hyderabad, AndhraPradesh, India, is a publicly-held pharmaceutical manufacturing companyoperating in compliance with Good Manufacturing Practices guidelines. Neulandproduces pharmaceuticals for a broad range of diseases and therapeutic areas,including respiratory, cardiovascular, infectious diseases, central nervoussystem disorders, and gastrointestinal. Neuland also provides chemistry-basedcontract research services in the areas of medicinal chemistry, process R&D,analytical R&D and scale-up activities. Neuland, with over 750 employees, hascustomers in over 80 countries and has established subsidiaries in the US andJapan.
About Cato BioVentures
Cato BioVentures is the venture capital affiliate of Cato Research Ltd.For nearly 20 years, Cato BioVentures has assisted entrepreneurs andestablished management teams in building successful life science companies.Through strategic CRO service agreements with Cato Research, Cato BioVenturesinvests its in-kind CRO Service Capital(R) in innovative therapeutics, medicaldevices, diagnostics and platform tools and technologies for improved drugdiscovery and development, offering promising life science companies immediateaccess to a broad range of essential CRO services on
